Evidence map›Paper›PMID 32188601›Full record

ReviewDevelopment (Cambridge, England)2020

SUMOylation in development and neurodegeneration.

Tak-Yu Yau, Oscar Molina, Albert J Courey

Abstract readReview
In one paragraph

Review in Development (Cambridge, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Knocking Down PIAS3 Reduces HCell biochemistry and biophysics · 2024
    Article
  12. SUMO modifies GβL and mediates mTOR signaling.The Journal of biological chemistry · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tak-Yu YauDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095-1569, USA.
Oscar MolinaDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095-1569, USA.
Albert J CoureyDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095-1569, USA courey@chem.ucla.edu.ORCID 0000-0002-4840-1407

Funding

MARC U*STAR Program at the University of California, Los AngelesT34GM008563 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCEVOY, MEGAN M, POE, GINA R · 1996 to 2023
$9.7M
SUMO conjugation in cell biology and DevelopmentR01GM063596 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI COUREY, ALBERT J · 2001 to 2010
$1.7M
Enhancing the Efficiency of Non-REM Sleep Temporal Dynamics to Improve Insight LearningR21MH119020 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI POE, GINA R · 2019 to 2020
$442k
NIGMS NIH HHS R01 GM063596NIGMS NIH HHS T34 GM008563NIMH NIH HHS R21 MH119020
6 · The paper itself

Abstract

In essentially all eukaryotes, proteins can be modified by the attachment of small ubiquitin-related modifier (SUMO) proteins to lysine side chains to produce branched proteins. This process of 'SUMOylation' plays essential roles in plant and animal development by altering protein function in spatially and temporally controlled ways. In this Primer, we explain the process of SUMOylation and summarize how SUMOylation regulates a number of signal transduction pathways. Next, we discuss multiple roles of SUMOylation in the epigenetic control of transcription. In addition, we evaluate the role of SUMOylation in the etiology of neurodegenerative disorders, focusing on Parkinson's disease and cerebral ischemia. Finally, we discuss the possibility that SUMOylation may stimulate survival and neurogenesis of neuronal stem cells.

Indexed as

Growth and DevelopmentAnimalsHumansNerve DegenerationNeurodegenerative DiseasesNeurogenesisPlant DevelopmentProtein Processing, Post-TranslationalSignal TransductionSumoylationEpigeneticsNeurodegenerative disorderPost-translational protein modificationSignal transductionSUMOUbiquitin-like protein

Identifiers

PMID32188601
PMCPMC7097199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.